Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
暂无分享,去创建一个
[1] F. Iellamo,et al. Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients. , 2012, International journal of cardiology.
[2] E. Falk,et al. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. , 2012, Cardiovascular research.
[3] V. Serebruany,et al. Endothelial Progenitor Cells and Left Ventricle Function in Patients With Acute Myocardial Infarction: Potential Therapeutic Considertions , 2012, American journal of therapeutics.
[4] A. Zovein,et al. Hemogenic endothelium: origins, regulation, and implications for vascular biology. , 2011, Seminars in cell & developmental biology.
[5] A. Zeiher,et al. Epigenetic Regulation of Endothelial Lineage Committed Genes in Pro-Angiogenic Hematopoietic and Endothelial Progenitor Cells , 2011, Circulation research.
[6] G. Basso,et al. Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. , 2011, Cytotherapy.
[7] P. Tiberghien,et al. Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction , 2011, Basic Research in Cardiology.
[8] A. Pessina,et al. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling , 2011, Hypertension Research.
[9] Shao-Sung Huang,et al. Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy , 2011, Hypertension Research.
[10] M. Marescotti,et al. Optimized glycaemic control achieved with add‐on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine , 2011, Diabetes, obesity & metabolism.
[11] D. Ardigò,et al. Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[12] M. Pesce,et al. Endothelial Fate and Angiogenic Properties of Human CD34+ Progenitor Cells in Zebrafish , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[13] H. Masuda,et al. Methodological Development of a Clonogenic Assay to Determine Endothelial Progenitor Cell Potential , 2011, Circulation research.
[14] M. Puato,et al. ENDOTHELIAL PROGENITOR CELLS RELATIONSHIPS WITH CLINICAL AND BIOCHEMICAL FACTORS IN A HUMAN MODEL OF BLUNTED ANGIOTENSIN II SIGNALING: 4D.09 , 2011 .
[15] A. M. Leone,et al. Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study. , 2011, Atherosclerosis.
[16] H. Masuda,et al. CD34+ Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone Marrow , 2011, PloS one.
[17] G. Fadini. Is bone marrow another target of diabetic complications? , 2011, European journal of clinical investigation.
[18] E. Falk,et al. Flanking Recipient Vasculature, Not Circulating Progenitor Cells, Contributes to Endothelium and Smooth Muscle in Murine Allograft Vasculopathy , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[19] Marcello Rota,et al. Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism , 2011, Circulation.
[20] StevenWarach,et al. Stromal-Derived Factor-1α Correlates With Circulating Endothelial Progenitor Cells and With Acute Lesion Volume in Stroke Patients , 2011 .
[21] M. Luby,et al. Stromal-Derived Factor-1&agr; Correlates With Circulating Endothelial Progenitor Cells and With Acute Lesion Volume in Stroke Patients , 2011, Stroke.
[22] T. Tung,et al. Factors associated with purity, biological function, and activation potential of endothelial colony-forming cells. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.
[23] Michael D. Schneider,et al. Cardiac muscle regeneration: lessons from development. , 2011, Genes & development.
[24] C. Vrints,et al. The effect of acute exercise on endothelial progenitor cells is attenuated in chronic heart failure , 2011, European Journal of Applied Physiology.
[25] M. Hristov,et al. CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy. , 2011, European heart journal.
[26] R. Perlingeiro,et al. Clonal Analysis Reveals a Common Progenitor for Endothelial, Myeloid, and Lymphoid Precursors in Umbilical Cord Blood , 2010, Circulation research.
[27] M. Luby,et al. Endothelial progenitor cells correlate with lesion volume and growth in acute stroke , 2010, Neurology.
[28] S. Fichtlscherer,et al. Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol , 2010, PloS one.
[29] C. Siu,et al. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. , 2010, The American journal of cardiology.
[30] Jiemei Wang,et al. Impaired Endothelial Progenitor Cell Activity is Associated with Reduced Arterial Elasticity in Patients with Essential Hypertension , 2010, Clinical and experimental hypertension.
[31] G. Keren,et al. Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome. , 2010, World journal of cardiology.
[32] Y. Yoon,et al. CD31+ Cells Represent Highly Angiogenic and Vasculogenic Cells in Bone Marrow: Novel Role of Nonendothelial CD31+ Cells in Neovascularization and Their Therapeutic Effects on Ischemic Vascular Disease , 2010, Circulation research.
[33] H. Tse,et al. Low circulating level of CD133+KDR+cells in patients with systemic sclerosis. , 2010, Clinical and experimental rheumatology.
[34] L. Gandini,et al. HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects. , 2010, Microvascular research.
[35] Y. Yoon,et al. Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. , 2010, Journal of the American College of Cardiology.
[36] J. Lekakis,et al. Smoking and endothelial progenitor cells: a revision of literature. , 2010, Current pharmaceutical design.
[37] Luca Sterpone,et al. Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs , 2010, PloS one.
[38] J. Meigs,et al. Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis , 2010, PloS one.
[39] D. Fliser,et al. Endothelial Progenitor Cells and Cardiovascular Events in Patients with Chronic Kidney Disease – a Prospective Follow-Up Study , 2010, PloS one.
[40] A. Avogaro,et al. Potential manipulation of endothelial progenitor cells in diabetes and its complications , 2010, Diabetes, obesity & metabolism.
[41] G. Schuler,et al. Exercise Training in Patients With Advanced Chronic Heart Failure (NYHA IIIb) Promotes Restoration of Peripheral Vasomotor Function, Induction of Endogenous Regeneration, and Improvement of Left Ventricular Function , 2010, Circulation. Heart failure.
[42] T. Lüscher,et al. Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Prehypertension: Relation to Endothelial Dysfunction , 2010, Hypertension.
[43] G. Baumann,et al. Smoking decreases the level of circulating CD34+ progenitor cells in young healthy women - a pilot study , 2010, BMC women's health.
[44] A. Ramunni,et al. Effect of Low-Density Lipoprotein Apheresis on Circulating Endothelial Progenitor Cells in Familial Hypercholesterolemia , 2010, Blood Purification.
[45] K. Hirschi,et al. Hemato-vascular origins of endothelial progenitor cells? , 2010, Microvascular research.
[46] Djuro Josic,et al. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. , 2010, Experimental hematology.
[47] A. Avogaro,et al. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. , 2010, Atherosclerosis.
[48] Arjun Deb,et al. Hard luck stories: the reality of endothelial progenitor cells continues to fall short of the promise. , 2010, Circulation.
[49] A. Avogaro,et al. Reduced endothelial progenitor cells and brachial artery flow‐mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open‐angle glaucoma , 2010, Acta ophthalmologica.
[50] G. Hasenfuss,et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. , 2010, Journal of the American College of Cardiology.
[51] M. Wolzt,et al. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity , 2010, International Journal of Obesity.
[52] E. Dejana,et al. Levels of circulating pro-angiogenic cells predict cardiovascular outcomes in patients with chronic heart failure. , 2009, Journal of cardiac failure.
[53] A. Avogaro,et al. Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. , 2009, Atherosclerosis.
[54] A. Zeiher,et al. CXCR4 Expression Determines Functional Activity of Bone Marrow–Derived Mononuclear Cells for Therapeutic Neovascularization in Acute Ischemia , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[55] K. Plate,et al. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors , 2009, International journal of cancer.
[56] Fedor V. Karginov,et al. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. , 2009, Genes & development.
[57] Qingbo Xu,et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. , 2009, Blood.
[58] Stefanie Dimmeler,et al. MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.
[59] A. Reinisch,et al. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. , 2009, Blood.
[60] P. Home,et al. Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria , 2009, Diabetologia.
[61] I. Baumgartner,et al. Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell Transplantation , 2009, PloS one.
[62] A. Avogaro,et al. Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. , 2009, Atherosclerosis.
[63] C. Jung,et al. Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure , 2009, European journal of medical research.
[64] T. Soma,et al. Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[65] A. Avogaro,et al. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome. , 2009, Metabolic syndrome and related disorders.
[66] Georges Lacaud,et al. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage , 2009, Nature.
[67] A. Mügge,et al. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease , 2009, European journal of clinical investigation.
[68] J. Heymach,et al. Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses , 2009, Clinical Cancer Research.
[69] J. Rumberger,et al. Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk , 2009, Clinical medicine. Cardiology.
[70] R. Autorino,et al. Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. , 2009, The journal of sexual medicine.
[71] Hiroshi Takahashi,et al. Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. , 2008, Kidney international.
[72] F. Kiessling,et al. Sustained Persistence of Transplanted Proangiogenic Cells Contributes to Neovascularization and Cardiac Function After Ischemia , 2008, Circulation research.
[73] K. Chayama,et al. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. , 2008, American journal of hypertension.
[74] K. Hirschi,et al. Embryonic vasculogenesis and hematopoietic specification , 2008, Organogenesis.
[75] K. Hirschi,et al. Assessing identity, phenotype, and fate of endothelial progenitor cells. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[76] Anders Larsson,et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.
[77] A. Avogaro,et al. Gender Differences in Endothelial Progenitor Cells and Cardiovascular Risk Profile: The Role of Female Estrogens , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[78] A. Avogaro,et al. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. , 2008, Atherosclerosis.
[79] A. Oliveras,et al. Endothelial progenitor cells are reduced in refractory hypertension , 2008, Journal of Human Hypertension.
[80] R. Lavery,et al. Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes , 2008, Diabetologia.
[81] D. Celermajer,et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. , 2008, Journal of the American College of Cardiology.
[82] Cheng-Hsien Lu,et al. Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke , 2008, Stroke.
[83] M. Flesch,et al. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. , 2007, European heart journal.
[84] Stefanie Dimmeler,et al. Cell-Based Therapy of Myocardial Infarction , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[85] E. Peterson,et al. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. , 2007, Journal of the American College of Cardiology.
[86] G. Biondi-Zoccai,et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. , 2007, Journal of the American College of Cardiology.
[87] Qingbo Xu,et al. Endothelial Progenitor Cells, Cardiovascular Risk Factors, Cytokine Levels and Atherosclerosis – Results from a Large Population-Based Study , 2007, PloS one.
[88] Ju-Young Kim,et al. Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies , 2007, Circulation.
[89] R. Paltriccia,et al. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients , 2007, Journal of hypertension.
[90] A. Avogaro,et al. Critical assessment of putative endothelial progenitor phenotypes. , 2007, Experimental hematology.
[91] O. Hurtado,et al. The Increase of Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke Is Associated With Good Outcome , 2007, Stroke.
[92] A. Avogaro,et al. Endothelial progenitor cells in the natural history of atherosclerosis. , 2007, Atherosclerosis.
[93] M. Yoder,et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.
[94] A. Reinisch,et al. Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro , 2007, Stem cells.
[95] A. Avogaro,et al. Glucose tolerance is negatively associated with circulating progenitor cell levels , 2007, Diabetologia.
[96] C. Heeschen,et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. , 2007, Journal of the American College of Cardiology.
[97] U. Gehling,et al. Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension. , 2007, Stem cells and development.
[98] Shing‐Jong Lin,et al. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X , 2007, Heart.
[99] H. Tse,et al. Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension , 2007, Journal of Human Hypertension.
[100] A. Simon,et al. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. , 2007, Atherosclerosis.
[101] J. Prchal,et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.
[102] W. Shen,et al. Circulating Endothelial Progenitor Cells, C-Reactive Protein and Severity of Coronary Stenosis in Chinese Patients with Coronary Artery Disease , 2007, Hypertension Research.
[103] A. Lechi,et al. Endothelial progenitor cells in patients with essential hypertension , 2007, Journal of hypertension.
[104] N. Chaturvedi,et al. Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis , 2007, European journal of clinical investigation.
[105] B. Blanco,et al. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. , 2007, Cytotherapy.
[106] C. Stefanadis,et al. Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. , 2006, Atherosclerosis.
[107] T. Asahara,et al. CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells , 2006, Circulation.
[108] D. Link,et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. , 2006, Journal of the American College of Cardiology.
[109] J. Leor,et al. Endothelial progenitors: a new Tower of Babel? , 2006, Journal of the American College of Cardiology.
[110] A. Avogaro,et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. , 2006, European heart journal.
[111] A. Avogaro,et al. Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[112] A. Avogaro,et al. Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population , 2006, Stroke.
[113] A. Rivard,et al. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. , 2006, Atherosclerosis.
[114] Doris A Taylor,et al. Circulating endothelial progenitor cells predict coronary artery disease severity. , 2006, American heart journal.
[115] Zhu Junhui,et al. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. , 2006 .
[116] G. Nickenig,et al. CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.
[117] D. Strunk,et al. Blood Monocytes Mimic Endothelial Progenitor Cells , 2006, Stem cells.
[118] Jun-zhu Chen,et al. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. , 2006, Archives of medical research.
[119] C. Heeschen,et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. , 2005, Journal of molecular and cellular cardiology.
[120] Hyun-Jai Cho,et al. Cytokines and Matrix Metalloproteinases Progenitor Cells and Late Outgrowth Endothelial Cells: the Role of Angiogenic Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Ou , 2022 .
[121] G. Nickenig,et al. Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.
[122] Luigi Naldini,et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.
[123] M. Yoder,et al. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. , 2005, Blood.
[124] S. Fichtlscherer,et al. Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.
[125] A. M. Leone,et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. , 2005, European heart journal.
[126] R. Brandes,et al. Cell-to-Cell Connection of Endothelial Progenitor Cells With Cardiac Myocytes by Nanotubes: A Novel Mechanism for Cell Fate Changes? , 2005, Circulation research.
[127] A. Avogaro,et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.
[128] M. Kelm,et al. Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.
[129] R. Neuwirth,et al. SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. , 2005, Diabetes care.
[130] D. Fliser,et al. Stimulation of Endothelial Progenitor Cells: A New Putative Therapeutic Effect of Angiotensin II Receptor Antagonists , 2005, Hypertension.
[131] A. Zeiher,et al. p38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells , 2005, Circulation.
[132] A. Zeiher,et al. Mobilizing endothelial progenitor cells. , 2005, Hypertension.
[133] Françoise Dignat-George,et al. Circulating endothelial cells , 2005, Thrombosis and Haemostasis.
[134] K. Todd,et al. Endothelial Progenitor Cells During Cerebrovascular Disease , 2005, Stroke.
[135] L. Tavazzi,et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.
[136] G. Stassi,et al. Transplantation of low dose CD34+Kdr+ cells promotes vascular and muscular regeneration in ischemic limbs , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[137] T. Katagiri,et al. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[138] K. Pollok,et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.
[139] K. Alitalo,et al. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. , 2004, Blood.
[140] R. Ferrari,et al. CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure , 2004, Circulation.
[141] Xing-xiang Wang,et al. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. , 2004, Clinical science.
[142] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[143] M. Hayashi,et al. Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[144] D. Rizzoni,et al. Prevalence of Fetal-Type Smooth Muscle Cells in the Media of Microvessels From Hypertensive Patients , 2004, Hypertension.
[145] C. Temm,et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. , 2004, Journal of the American College of Cardiology.
[146] W. Schaper,et al. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. , 2004, Circulation research.
[147] H. Miller,et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. , 2004, European heart journal.
[148] Hyun-Jae Kang,et al. Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[149] Frank J T Staal,et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.
[150] M. Wong,et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. , 2004, Blood.
[151] Stefanie Dimmeler,et al. Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells , 2003, Circulation.
[152] A. Quyyumi,et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.
[153] M. Hristov,et al. Endothelial progenitor cells: isolation and characterization. , 2003, Trends in cardiovascular medicine.
[154] Christie M. Orschell,et al. Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.
[155] Y. Yoon,et al. Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.
[156] S. Fichtlscherer,et al. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.
[157] S. Fichtlscherer,et al. Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.
[158] T. Murohara,et al. Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.
[159] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[160] S. Dirnhofer,et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells , 2000, The Lancet.
[161] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[162] K. Pantel,et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.
[163] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.